Figure 5.
(A) Effect of angiotensin‐converting enzyme inhibitors (ACE‐Is) and angiotensin receptor blockers (RCBs) on hospitalizations due to heart failure in patients with heart failure with preserved ejection fraction. (B) Effect of ACE‐I and RCBs on hospitalizations or mortality in patients with heart failure with preserved ejection fraction. CI, confidence interval; RCT, randomized clinical trial; RR, relative risk.